The importance of GABA signaling/metabolism in breast cancer metastasis is illustrated by the four independent patient datasets wherein decreased ABAT expression (and inferred increased GABA signaling/metabolism) was strongly and significantly associated with an increased risk of brain and lung metastasis. This evidence concerns the gene ABAT and breast carcinoma.